The advantage of Tf introduction into the formulation was more evident when investigating the effect of the NPs-ZOL-Tf in an orthotopic model of GBM, in which the drug has not only to reach the tumor, but also to cross the BBB. This evidence concerns the gene TF and glioblastoma.